Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Consequences of Direct-to-Consumer Advertising
Links to Higher Prices and Less Competition

DTC Drug Cost LinkThis article focuses on a new study that suggests drug price increases are engineered to cover the costs of Direct-to-Consumer Advertising (DTCA). Drug price trend data from AARP, AHRQ, and prescription drug consumer price index (CPI) are presented.

Topic headings include:
  • AARP Rx Watchdog Report Data
  • Flaws in the AARP Report
  • Engineered Drug Price Increase
  • DTC Ad Spend Chart
  • Industry Says No Direct Link to DTC
  • Plavix and Medicaid
  • Smoking Gun Charts
  • Pharmacos Spend More on DTCA When There is No Competition
  • Plausible or Dubious?

Read this article now. It's FREE...

Download PDF file

PMN810-01
Issue: Vol. 8, No. 10: Nov/Dec 2009
Word Count: 2802

Find other articles in related Topic Areas:

Vol 8, #10 Contents








Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.